AI Automated Translation.

Font Size

Share

Dongwon Parts, Baro Farm, Nexi… Three Companies to Debut on KOSDAQ Next Week

Dongwon Parts, Baro Farm, Nexi… Three Companies to Debut on KOSDAQ Next Week

[IPO Briefing]

Key IPO Schedule for the 9th–13 / Graphic = Lee Ji-hye
Key IPO Schedule for the 9th–13 / Graphic = Lee Ji-hye

Three companies will debut on the KOSDAQ market this week. New listings from diverse sectors, including semiconductor components, healthcare-related platforms, and new drug development, are set to be listed. While some companies showed sluggish performance in demand forecasting due to stock market corrections, others achieved successful subscriptions with a competition ratio of 1,200-to-1, revealing varying levels of investor interest by company.

According to the financial investment industry on the 8th, three companies—Dongwon Parts, Baro Farm, and Nexi—are scheduled to be listed on the KOSDAQ market from the 9th to the 13th.

“Dongwon Parts,” which will be listed on the 10th, is a manufacturer of precision components for semiconductor equipment. Since its establishment in 1997, it has supplied customer-tailored components to global and major domestic semiconductor equipment companies for approximately 29 years. Its main products include shower heads, chamber parts, heaters, and spin chucks used in front-end semiconductor process (etching, deposition, cleaning, ion implantation, etc.) equipment. Major clients include Lam Research, Applied Materials, Excelsior, Mason, {Semis}, PSK, and Wonik IPS. Its revenue composition is 51% overseas and 49% domestic.

Dongwon Parts recorded a competition ratio of 840.86-to-1 in the demand forecasting conducted from the 22nd to the 28th of last month targeting domestic and foreign institutional investors, finalizing its IPO price at 26,500 won, the top of the desired price band. More than 96% of institutional investors submitted their desired prices at the top of the band. The mandatory holding commitment ratio is 16.61%. The tradable volume immediately after listing is 17.52%, which is 11.97 percentage points lower than the initial estimate of 29.49%.

Dongwon Parts’ IPO amount is 53.795 billion won, and its expected market capitalization after listing is 245.8 billion won. In the general subscription conducted on the 2nd and 3rd, it recorded a competition ratio of 1,219.37-to-1, raising approximately 8.2 trillion won in collateral. The lead underwriter is Samsung Securities.

“Baro Farm,” which will be listed on the 11th, is a pharmacy ordering platform company. It develops and operates a healthcare platform that supports the efficiency of pharmaceutical ordering and management operations. Based on a network of approximately 24,000 registered pharmacies nationwide, it supports transactions and information transmission between pharmacies and pharmaceutical companies or wholesalers, and provides services connecting patients and consumers with pharmacies. The company plans to expand into overseas markets such as North America in the future, distributing partner brands including beauty products sold through pharmacy-based channels.

In the institutional investor demand forecasting conducted from the 22nd to the 28th of last month, Baro Farm finalized its IPO price at 16,400 won, the bottom of the desired price band, with a competition ratio of 152.36-to-1. Approximately 54.5% of the participating institutions in the demand forecasting wrote values lower than the bottom of the band. The mandatory holding commitment application ratio is 0.03%.

Baro Farm’s IPO amount is 29.192 billion won, and its expected market capitalization after listing is 195.9 billion won. In the general public subscription conducted on the 2nd and 3rd, it raised approximately 70.3 billion won in collateral with a competition ratio of 19.27-to-1. The lead underwriter is Mirae Asset Securities.

Nexi, an immune-oncology new drug development company, will debut on the KOSDAQ market on the 12th. Since its establishment in 2021, it has been identifying causal factors that do not respond to immune-oncology agents and developing anti-cancer new drugs targeting them.

In the institutional investor demand forecasting conducted from the 22nd to the 28th of last month, Nexi recorded a competition ratio of 66.58-to-1 and finalized its IPO price at 8,000 won, which is below the desired band of 10,500 to 13,000 won. 48.15% of the institutional investors participating in the demand forecasting proposed an IPO price below the bottom of the band. The mandatory holding commitment application ratio is 0.06%.

Nexi’s IPO amount is 40 billion won, and its expected market capitalization after listing is approximately 366.8 billion won. In the general public subscription conducted on the 3rd and 4th, it recorded a competition ratio of 13.26-to-1, raising approximately 66.3 billion won in collateral. The lead underwriter is Korea Investment & Securities.

Five companies—JNTG, CNM, Ucast, SFC, and Adel—are conducting institutional investor demand forecasting between the 9th and the 13th. Among them, SFC is pursuing a listing on the KOSPI. The desired IPO price bands are: JNTG 26,400 to 31,900 won, CNM 10,000 to 13,000 won, Ucast 19,000 to 23,000 won, SFC 31,600 to 36,100 won, and Adel 18,000 to 25,000 won.

Five companies—AL Robot, Hana Aerodynamics, JNTG, CNM, and MBD—are conducting general subscriptions during the same period. Among them, AL Robot has finalized its IPO price at 17,600 won, the top of the desired band.

"This article was translated using AI and may differ slightly from the original."